Severin Daum

7PUBLICATIONS
9CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2022
Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort.

Jan Schölzchen, Christoph Treese, Peter Thuss-Patience

|Apr 21, 2022
Hereditary Diffuse Gastric Cancer-Update Based on the Current Consort Recommendations.

Christoph Treese, Britta Siegmund, Severin Daum

|Apr 12, 2022
Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas.

Christoph Treese, Jessica Werchan, Moritz von Winterfeld

|Mar 25, 2022
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus.

Christoph Treese, Kimberly Hartl, Michelle Pötzsch

|Mar 05, 2022
Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.

Karsten Kleo, Vladimir M Jovanovic, Alexander Arndold

|Dec 14, 2021
[Long-term response in advanced pancreatic adenocarcinoma - a case report and literature review].

Paola Cura Daball, Hanno Tröger, Severin Daum

Pageof 2

Frequent Collaborators

4 joint publications

Christoph Treese

3 joint publications

Beate Rau

2 joint publications

Ulrike Stein

1 joint publications

Michael Schumann